Harpoon Therapeutics (HARP) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Harpoon Therapeutics Short Interest Data

Current Short Interest
538,400 shares
Previous Short Interest
1,160,000 shares
Change Vs. Previous Month
-53.59%
Dollar Volume Sold Short
$12.35 million
Short Interest Ratio
0.5 Days to Cover
Last Record Date
February 29, 2024
Outstanding Shares
16,932,000 shares
Float Size
12,500,000 shares
Short Percent of Float
4.31%
Today's Trading Volume
0 shares
Average Trading Volume
1,516,200 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Harpoon Therapeutics ?

Sign up to receive the latest short interest report for Harpoon Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HARP Short Interest Over Time

HARP Days to Cover Over Time

HARP Percentage of Float Shorted Over Time

Harpoon Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/29/2024538,400 shares $12.35 million -53.6%4.3%0.5 $22.94
2/15/20241,160,000 shares $26.02 million +111.8%11.7%1.2 $22.43
1/31/2024547,700 shares $12.23 million +15.2%5.5%0.8 $22.33
1/15/2024475,400 shares $10.65 million -43.5%4.1%0.9 $22.40
12/31/2023841,300 shares $9.57 million +75.4%7.1%2 $11.37
12/15/2023479,700 shares $4.87 million +21.2%4.1%2.3 $10.16
11/30/2023395,800 shares $4.20 million +55.0%3.4%2.2 $10.60
11/15/2023255,300 shares $2.22 million +7.2%1.9%1.6 $8.69
10/31/2023238,200 shares $1.20 million +400.4%45.3%2 $5.04
10/15/202347,600 shares $198,492.00 +7.0%1.8%0.5 $4.17
9/30/202344,500 shares $179,335.00 +61.8%1.7%1.2 $4.03
9/15/202327,500 shares $138,875.00 -25.5%1.0%0.8 $5.05
8/31/202336,900 shares $383,760.00 -63.9%1.4%1.3 $10.40
8/15/2023102,100 shares $82,496.80 -34.8%0.4%0.5 $0.81
7/31/2023156,700 shares $122,743.11 +16.8%0.6%0.8 $0.78
7/15/2023134,200 shares $103,334.00 -71.7%0.5%0.7 $0.77
6/30/2023473,300 shares $336,043.00 +10.4%1.9%2.3 $0.71
6/15/2023428,600 shares $318,921.26 +51.5%1.7%2.1 $0.74
5/31/2023283,000 shares $192,440.00 -32.3%1.1%1.3 $0.68
5/15/2023417,700 shares $313,776.24 -45.1%1.7%1.8 $0.75
4/30/2023761,200 shares $445,378.12 +115.5%3.3%2.5 $0.59
4/15/2023353,200 shares $248,299.60 -4.5%1.5%0.9 $0.70
3/31/2023370,000 shares $275,354.00 -4.6%1.7%0.9 $0.74
3/15/2023387,700 shares $294,652.00 +60.6%2.0%0.8 $0.76
2/28/2023241,400 shares $186,940.16 +32.6%1.3%0.1 $0.77
2/15/2023182,000 shares $147,420.00 -53.6%1.0%0.1 $0.81
1/31/2023392,100 shares $423,468.00 +112.6%2.0%0.2 $1.08
1/15/2023184,400 shares $153,420.80 -80.2%1.0%0.1 $0.83
12/30/2022932,300 shares $676,570.11 -21.7%5.2%0.5 $0.73
12/15/20221,190,000 shares $858,347.00 +111.3%6.7%0.6 $0.72
11/30/2022563,100 shares $385,779.81 +15.1%3.2%3.3 $0.69
11/15/2022489,300 shares $398,094.48 +21.0%2.8%3.1 $0.81
10/31/2022404,400 shares $369,540.72 +0.3%2.3%2.6 $0.91
10/15/2022403,300 shares $399,831.62 +3.9%2.3%2.6 $0.99
9/30/2022388,000 shares $376,398.80 -9.3%2.2%2.4 $0.97
9/15/2022427,800 shares $693,036.00 +3.0%2.4%2.3 $1.62
8/31/2022415,400 shares $689,564.00 -6.2%2.4%2.5 $1.66
8/15/2022442,900 shares $947,806.00 -14.9%2.5%2.2 $2.14
7/31/2022520,700 shares $1.02 million -7.8%3.0%2.2 $1.95
7/15/2022564,700 shares $1.42 million -7.0%3.2%2.3 $2.52
Everybody laughed when he recommended Netflix (Ad)

"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Click here to see how it could become the No. 1 investment of the next decade.
6/30/2022607,400 shares $1.16 million -49.0%3.5%2.1 $1.91
6/15/20221,190,000 shares $2.39 million +6.3%6.8%4 $2.01
5/31/20221,120,000 shares $2.31 million +4.7%6.4%3.7 $2.06
5/15/20221,070,000 shares $2.14 million -7.8%6.1%2.8 $2.00
4/30/20221,160,000 shares $2.61 million +7.4%6.6%3.3 $2.25
4/15/20221,080,000 shares $3.51 million +0.9%6.2%3.1 $3.25
3/31/20221,070,000 shares $5.32 million +8.9%6.1%3.2 $4.97
3/15/2022982,400 shares $3.52 million +15.7%5.5%2.9 $3.58
2/28/2022849,000 shares $3.48 million +0.4%4.8%2.7 $4.10
2/15/2022845,900 shares $4.79 million -1.3%4.8%3.5 $5.66
1/31/2022857,300 shares $4.54 million +17.0%4.8%3.4 $5.29
1/15/2022732,600 shares $4.29 million +2.7%N/A2.7 $5.85
12/31/2021713,200 shares $5.38 million -7.6%4.0%2.6 $7.55
12/15/2021771,800 shares $5.14 million -13.4%4.3%2.7 $6.66
11/30/2021891,100 shares $5.47 million -0.5%5.0%2.9 $6.14
11/15/2021895,600 shares $6.56 million +1.8%4.3%2.7 $7.33
10/29/2021879,800 shares $5.51 million -1.5%4.3%2.5 $6.26
10/15/2021892,900 shares $6.18 million +7.3%4.4%2.1 $6.92
9/30/2021832,000 shares $6.57 million -45.3%4.1%1.8 $7.90
9/15/20211,520,000 shares $13.01 million -40.6%7.4%3.1 $8.56
8/31/20212,560,000 shares $24.27 million +2.4%12.5%5.1 $9.48
8/13/20212,500,000 shares $22.43 million -10.7%12.1%4.9 $8.97
7/30/20212,800,000 shares $27.41 million +36.6%15.4%5.8 $9.79
7/15/20212,050,000 shares $25.07 million +4.6%10.0%5.4 $12.23
6/30/20211,960,000 shares $27.19 million +69.0%9.6%6.1 $13.87
6/15/20211,160,000 shares $17.67 million +35.4%5.7%3.9 $15.23
5/28/2021857,000 shares $17.67 million -8.1%4.2%3.3 $20.62
5/14/2021932,800 shares $18.47 million -11.2%4.6%3.9 $19.80
4/30/20211,050,000 shares $23.43 million -9.5%5.2%4.4 $22.31
4/15/20211,160,000 shares $23.90 million +9.4%5.9%4.7 $20.60
3/31/20211,060,000 shares $20.79 million +33.8%4.6%3.5 $19.61
3/15/2021792,500 shares $15.46 million +4.6%3.4%2.6 $19.51
2/26/2021757,800 shares $13.88 million +11.8%3.3%2.5 $18.31
2/12/2021678,000 shares $14.08 million -5.8%2.9%2.5 $20.77
1/29/2021719,700 shares $13.43 million -4.2%3.5%2.9 $18.66
1/15/2021751,500 shares $16.05 million -11.3%3.9%3.3 $21.36
12/31/2020847,500 shares $14.09 million +23.0%4.6%4.3 $16.63
12/15/2020688,800 shares $9.73 million -13.2%4.6%4.7 $14.13
11/30/2020793,700 shares $11.78 million -1.4%5.3%5.5 $14.84
11/15/2020804,900 shares $12.56 million -6.2%5.4%4.8 $15.60
10/30/2020858,500 shares $12.97 million -0.1%5.7%2.8 $15.11
10/15/2020859,500 shares $13.89 million -2.4%5.8%2.6 $16.16
9/30/2020880,600 shares $14.96 million +6.5%5.9%2.6 $16.99
9/15/2020826,600 shares $13.14 million +27.3%5.6%2.4 $15.90
8/31/2020649,200 shares $8.93 million -0.5%4.4%2 $13.76
8/14/2020652,700 shares $7.92 million +1.3%4.4%2 $12.13
7/31/2020644,300 shares $7.09 million +23.2%4.4%3.1 $11.01
7/15/2020522,900 shares $7.87 million +17.2%3.6%2.8 $15.06
6/30/2020446,300 shares $7.36 million +102.1%3.1%2.6 $16.49
6/15/2020220,800 shares $3.89 million +4.5%1.5%1.5 $17.64
Everybody laughed when he recommended Netflix (Ad)

"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Click here to see how it could become the No. 1 investment of the next decade.
5/29/2020211,300 shares $4.60 million -33.3%1.5%1.4 $21.76
5/15/2020316,700 shares $4.57 million +29.1%2.2%2.9 $14.43
4/30/2020245,300 shares $3.09 million -21.9%1.7%3 $12.60
4/15/2020314,100 shares $3.89 million +0.7%2.2%3.2 $12.40
3/31/2020311,900 shares $3.88 million +7.9%2.2%2.9 $12.43
3/13/2020289,000 shares $3.31 million +12.9%2.1%4.4 $11.47
2/28/2020256,100 shares $2.86 million +1.8%1.9%1.9 $11.15
2/14/2020251,600 shares $3.56 million -28.3%1.8%1.8 $14.16
1/31/2020351,000 shares $5.17 million +6.7%2.6%2.5 $14.73
1/15/2020329,000 shares $5.26 million +32.1%2.4%2.9 $15.98
12/31/2019249,100 shares $3.64 million +1.9%1.8%2.5 $14.62
8/15/2019180,000 shares $2.52 million -11.8%2.1%7.4 $13.99

HARP Short Interest - Frequently Asked Questions

What is Harpoon Therapeutics' current short interest?

Short interest is the volume of Harpoon Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 538,400 shares of HARP short. 4.31% of Harpoon Therapeutics' shares are currently sold short. Learn More on Harpoon Therapeutics' current short interest.

What is a good short interest percentage for Harpoon Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.31% of Harpoon Therapeutics' floating shares are currently sold short.

Is Harpoon Therapeutics' short interest increasing or decreasing?

Harpoon Therapeutics saw a decline in short interest in February. As of February 29th, there was short interest totaling 538,400 shares, a decline of 53.6% from the previous total of 1,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Harpoon Therapeutics' float size?

Harpoon Therapeutics currently has issued a total of 16,932,000 shares. Some of Harpoon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harpoon Therapeutics currently has a public float of 12,500,000 shares.

How does Harpoon Therapeutics' short interest compare to its competitors?

4.31% of Harpoon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Harpoon Therapeutics: Terns Pharmaceuticals, Inc. (10.91%), LifeMD, Inc. (8.10%), ModivCare Inc. (7.13%), Aurora Cannabis Inc. (34.02%), Anika Therapeutics, Inc. (5.64%), Korro Bio, Inc. (2.68%), Cerus Co. (3.09%), Organogenesis Holdings Inc. (12.55%), Solid Biosciences Inc. (3.01%), Verrica Pharmaceuticals Inc. (14.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks.

What does it mean to sell short Harpoon Therapeutics stock?

Short selling HARP is an investing strategy that aims to generate trading profit from Harpoon Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Harpoon Therapeutics?

A short squeeze for Harpoon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HARP, which in turn drives the price of the stock up even further.

How often is Harpoon Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HARP, twice per month. The most recent reporting period available is February, 29 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:HARP) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners